Northern Trust’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
Northern Trust's XGN Position: Q2 2026 in Review
Northern Trust increased its Exagen (XGN) stake by 5.2% in Q2 2026, buying an estimated $7.39K and bringing the position to 39,513 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3961.
Northern Trust first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.46M in Q2 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- Northern Trust held 39,513 shares of Exagen worth $184K as of Q2 2026.
- Northern Trust bought 1,964 Exagen shares in Q2 2026, an estimated $7.39K.
- Exagen made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3961 holding.
- Northern Trust first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
- Northern Trust's Exagen position peaked at $1.46M in Q2 2021.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.